Publication | Closed Access
Efficacy and safety of tenofovir DF (DF) in chronic hepatitis B virus infected patients with documented lamivudine resistance (LAM-R)
10
Citations
0
References
2012
Year
Unknown Venue
HepatologyViral HepatitisAntiviral Drug DevelopmentHepatitis BHepatitisTenofovir DfAntiviral TherapyChronic Viral InfectionAntiviral DrugDocumented Lamivudine ResistanceMedicine
No additional data available for this publication yet. Check back later!